Synapticure, a Chicago, IL-based teleneurology company providing personalized care for people living with ALS (Amyotrophic Lateral Sclerosis) and their families, launched with $6m in seed funding.
The round was led by GV (formerly Google Ventures) with participation from LifeForce Capital, Martin Ventures, Byers Capital, and Y-Combinator, as well as angel investors including David Hodgson (General Atlantic), Ron Conway (SV Angel), Joe Kraus (Lime), Jeff Huber (GRAIL), Adam Koppel (Bain Capital), Gerald E. “Gary” Bisbee (Cerner), Rohan Seth (Clubhouse), and Ben and Divya Silbermann (Pinterest/Tambourine).
The company will use the new capital to rapidly scale its care platform to people living with ALS across the United States.
Founded by Brian Wallach and Sandra Abrevaya, Synapticure provides a new telemedicine-centric model for ALS care built by and for those living with ALS, in collaboration with ALS clinics across the country, including Massachusetts General Hospital and University of California San Francisco.
The company is building a full-stack teleneurology platform that provides access and continuity of care to people living with ALS. This includes developing personalized care plans for each patient through testing, data analytics and consultations with ALS specialists at Synapticure and collaborating ALS clinics.
Synapticure’s team, board of directors and advisory board includes:
- Jinsy Andrews, MD, Synapticure Chief Medical Officer
- Peter Wallach, Synapticure Chief Financial Officer, Co-Founder and Board Member
- Jason Langheier, MD, Synapticure Co-Founder and Board Co-Chair, and Founder and CEO of Foodsmart
- Jonathan Hirsch, Synapticure Co-Founder and Board of Advisors Chair, Founder and Former President of Syapse
- Geoff Clapp, Synapticure Product and Technology Advisor, and SVP Optum Health Solutions (KRS)
- Sami Barmada, MD, PhD, University of Michigan Brain Bank Director and Neurology Associate Professor at University of Michigan Medical School
- Nathan Bays, Board of Directors, Unite US
- Robert Bowser, PhD, Deputy Chief Scientific Officer of Barrow Neurological Institute
- Aaron Gitler, PhD, Professor of Genetics at Stanford University
- Jeff Rothstein, MD, PhD, Director and Founder, Robert Packard Center for ALS Research at John Hopkins Medicine
- Ethan Perlstein, PhD, Founder and CEO of Perlara
- Chhaya Shadra, Data and Product Strategy Advisor
- Jeremy Shefner, MD, PhD, Chair of Neurology, Senior Vice President, Barrow Neurological Institute
- Lisa Suennen, Managing Partner, Venture Valkyrie, Faculty, Haas School of Business, UC Berkeley
FinSMEs
02/02/2022